Abstract
Endometriosis is a gynecological disease characterized by the presence of uterine (eutopic) endometrial glands and tissues outside the intra-uterine locations, in ectopic regions such as the pelvic peritoneum, fallopian tubes, or ovaries. Approximately 5-10% of reproductive and 20-50% of infertile women are affected by endometriosis. The pathogenesis of endometriosis involves various factors, including hormonal, environmental, genetic, and immune system components, directly or indirectly altering estrogen levels and impacting women’s reproductive health.This study aimed to identify novel and potential biomarkers for endometriosis using mRNA seq analysis. Differentially expressed genes (DEGs) were identified from raw gene expression profiles, and their functional analysis was subsequently conducted. A total of 552 DEGs (312 upregulated and 240 downregulated) were identified in samples from women with endometriosis compared to control subjects.Major DEGs, such as C3, PSAP, APP, GNG12, were identified as hub nodes and found to be involved in various functions, including epithelial cell differentiation and development, proteolysis, gland development, muscle fiber development, and response to hormone stimulus. These DEGs may play a direct or indirect role in the pathogenesis of endometriosis, serving as potential biomarkers for ectopic endometrium. While this study provides a preliminary insight into the mechanism of endometriosis, further detailed studies are necessary to fully understand its path of action.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
From the National Center of Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/), the raw gene expression profile datasets (ID: GSE7305) were obtained for this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The English language of the manuscript Improved.
Data Availability
All data produced in the present work are contained in the manuscript
